Bronchiolitis epidemiology after the COVID-19 pandemic: a partial return toward pre-pandemic patterns? An Italian surveillance study
Year: 2026
Type: article
Study design: Observational Study
Abstract: The COVID-19 pandemic and related interventions disrupted the typical seasonal patterns of bronchiolitis, leading to a significant decline in hospitalizations and disease severity. However, during the 2022–2023 winter season, bronchiolitis cases surged, with both the number of hospitalizations and disease severity exceeding pre-pandemic levels. Given these fluctuations, we considered it crucial to monitor the burden of bronchiolitis, particularly in light of the upcoming universal respiratory syncytial virus prophylactic antibody coverage in Italy. We retrospectively evaluated bronchiolitis-related hospitalizations and disease severity in infants (< 1 year) during winter seasons (September 1st to March 31st) across seven Italian hospitals from 2018 to 2019 through 2023–2024. A total of 833 infants were hospitalized for bronchiolitis during the 2023–2024 winter season across the seven participating hospitals, decreasing from 1102 in 2022–2023 and representing the first decline since the 2021–2022 season. The proportion of tested infants who were RSV-positive did not differ significantly between 2023 and 2024 and 2022–2023 (82% vs. 79%); the fall in RSV-positive admissions therefore mirrored the overall decline in hospitalization numbers rather than a reduction in RSV positivity. Compared with 2022–2023, a significantly smaller proportion of infants required oxygen supplementation, high-flow nasal cannula, or intensive care unit admission, although the duration of respiratory support among infants who required it did not decrease and was, if anything, marginally longer. Hospital length of stay did not differ significantly between the two seasons. Several indicators - including RSV positivity and the proportion of infants requiring oxygen or high-flow nasal cannula - remained significantly higher than pooled pre-pandemic (2018–2020) values, while the proportion requiring intensive care unit admission had returned to a level statistically similar to the pre-pandemic period. Our findings indicate a partial return toward pre-pandemic bronchiolitis epidemiology during the 2023–2024 winter season, with fewer infants requiring escalated respiratory support than in 2022–2023, although several indicators remained above pre-pandemic levels. Continued monitoring remains important, particularly in anticipation of the upcoming respiratory syncytial virus prophylactic antibody program in Italy.
Authors: Sergio Ghirardo, Barbara Madini, Nicola Ullmann, Alessandro Zago, Michele Ghezzi, Enza D’Auria, Marta Minute, Stefano Martelossi, Anna Chiara Vittucci, Sara Procoli, Laura Dotta, Francesca Castelletti, Vincenzo Guaia, Alessia Rocchi, Beatrice Andrenacci, Francesca Maria Risso, Andrea Trombetta, Salvatore Aversa, Alessandro De Fanti, Maria Francesca Patria, Alessandro Amaddeo, Raffaele Badolato, Egidio Barbi, Renato Cutrera
Institutions: University of Trieste, IRCCS Materno Infantile Burlo Garofolo, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Bambino Gesù Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Ospedale dei Bambini Vittore Buzzi, Ca' Foncello Hospital, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Brescia, Azienda Sanitaria Unità Locale di Reggio Emilia
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Keywords: bronchiolitis, respiratory syncytial virus, COVID-19 pandemic, infant hospitalization, disease severity, respiratory support, intensive care unit admission, RSV prophylaxis, seasonal patterns, Italy, hospital surveillance, length of hospital stay, supplemental oxygen, high-flow nasal cannula, pre-pandemic trends
Open Access status: gold
Estimated APC paid: $2,790
Funder: Ministero della Salute
OpenAlex ID: W7236216438
